{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:24:09Z","timestamp":1787772249153,"version":"build-2784847793"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Pityriasis Rosea (PR) is a common, yet enigmatic, dermatological condition characterized by a distinctive clinical presentation. Despite its prevalence, the aetiology and pathogenesis of PR remain elusive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To study the epidemiological and clinical aspects of patients with PR. To study dermoscopic findings and carry out histopathological correlation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A cross-sectional study of 50 patients was conducted. A detailed clinical history was taken and an examination was done followed by a dermoscopy. Quantitative data like age and duration of disease are presented with the help of standard deviation. Qualitative risk factors, like gender, age groups, symptomatology, site of lesion, findings or cutaneous examination, dermoscopy findings, and histopathology findings, are presented with the help of frequency and percentages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>PR shows male preponderance and mean age of occurrence being 30.8 \u00b1 15.7 years. Forty per cent of patients had an atypical clinical presentation. The most frequently seen dermoscopy findings were diffuse red background (58%), peripheral collarette scale (62%), and peripheral dotted vessels (50%). On histopathology, the most common findings were spongiosis (44%), parakeratosis (38%), irregular acanthosis (34%), perivascular lymphocytic infiltrate (56%), and red blood cell extravasation (36%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitations:<\/jats:title>\n                    <jats:p>Sample size was less due to COVID. As this was a corss-sectional study follow up of patients could not be done.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>While the diagnosis of PR is clinical, it is difficult in atypical cases where dermoscopy comes to the aid. It also helps identify the age of lesions, thus helping decide the treatment strategy for patients. Biopsy remains the gold standard in ruling out other differentials of PR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijd.ijd_1071_23","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T10:01:42Z","timestamp":1714384902000},"page":"145-151","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["A Cross-Sectional Study of Epidemiological and Clinical Aspects of Pityriasis Rosea along with Dermoscopic Analysis and Histopathology Correlation"],"prefix":"10.4103","volume":"69","author":[{"given":"Aditi A.","family":"Shende","sequence":"first","affiliation":[{"name":"From the Department of Dermatology, Venereology and Leprosy, Symbiosis Medical College for Women and Symbiosis University Health and Research Centre, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhi B.","family":"Chikhalkar","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprosy, Seth G S Medical College and KEM Hospital, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4,29]]},"reference":[{"key":"R2-20240829","doi-asserted-by":"crossref","first-page":"203","DOI":"10.12998\/wjcc.v5.i6.203","article-title":"Clinical variants of pityriasis rosea","volume":"5","author":"Urbina","year":"2017","journal-title":"World J Clin Cases"},{"key":"R4-20240829","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1586\/edm.10.28","article-title":"Current trends in pityriasis rosea","volume":"5","author":"Zawar","year":"2010","journal-title":"Expert Rev Dermatol"},{"key":"R5-20240829","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4103\/0019-5154.185699","article-title":"Pityriasis Rosea: An update on etiopathogenesis and management of difficult aspects","volume":"61","author":"Mahajan","year":"2016","journal-title":"Indian J Dermatol"},{"key":"R6-20240829","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1002\/jmv.26679","article-title":"Pityriasis rosea and COVID-19","volume":"93","author":"Veraldi","year":"2021","journal-title":"J Med Virol"},{"key":"R7-20240829","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/15569527.2016.1225217","article-title":"Atypical pityriasis rosea: Clinical evaluation of 27 patients","volume":"36","author":"Kilinc","year":"2017","journal-title":"Cutan Ocul Toxicol"},{"key":"R8-20240829","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/ds.ds_14_19","article-title":"Dermoscopic profile of pityriasis rosea","volume":"37","author":"Elmas","year":"2019","journal-title":"Dermatol Sin"},{"key":"R9-20240829","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1365-2133.2012.10868.x","article-title":"Accuracy of dermoscopic criteria for the diagnosis of psoriasis, dermatitis, lichen planus and pityriasis rosea","volume":"166","author":"Lallas","year":"2012","journal-title":"Br J Dermatol"},{"key":"R10-20240829","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.4081\/idr.2016.6418","article-title":"Pityriasis rosea, Gianotti-Crosti syndrome, asymmetric periflexural exanthem, papular-purpuric gloves and socks syndrome, eruptive pseudoangiomatosis, and eruptive hypomelanosis: do their epidemiological data substantiate infectious etiologies?","volume":"8","author":"Chuh","year":"2016","journal-title":"Infect Dis Rep"},{"key":"R11-20240829","first-page":"141","article-title":"A clinicoepidemiological study of pityriasis rosea in South India","volume":"11","author":"Ganguly","year":"2013","journal-title":"Skinmed"},{"key":"R12-20240829","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/1203475420902049","article-title":"Pityriasis Rosea: Risk and treatment during pregnancy","volume":"24","author":"Alajmi","year":"2020","journal-title":"J Cutan Med Surg"},{"key":"R13-20240829","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/jdv.12942","article-title":"Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: A review of the literature","volume":"30","author":"Drago","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R14-20240829","doi-asserted-by":"crossref","first-page":"e15129","DOI":"10.1111\/dth.15129","article-title":"Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review","volume":"34","author":"Pedrazini","year":"2021","journal-title":"Dermatol Ther"},{"key":"R15-20240829","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0190-9622(00)90132-4","article-title":"Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial","volume":"42","author":"Sharma","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"R16-20240829","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/0019-5154.44787","article-title":"Study of role of streptococcal throat infection in pityriasis rosea","volume":"53","author":"Parija","year":"2008","journal-title":"Indian J Dermatol"},{"key":"R17-20240829","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000245991","article-title":"Human herpesvirus 7 in patients with pityriasis rosea. Electron microscopy investigations and polymerase chain reaction in mononuclear cells, plasma and skin","volume":"195","author":"Drago","year":"1997","journal-title":"Dermatology"},{"key":"R18-20240829","doi-asserted-by":"crossref","first-page":"792","DOI":"10.4103\/0253-7613.103304","article-title":"Cutaneous adverse drug reaction profile in a tertiary care outpatient setting in Eastern India","volume":"44","author":"Saha","year":"2012","journal-title":"Indian J Pharmacol"},{"key":"R19-20240829","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.27364","article-title":"Atypical pityriasis rosea associated with mRNA COVID-19 vaccine","volume":"94","author":"Bostan","year":"2022","journal-title":"J Med Virol"},{"key":"R20-20240829","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1111\/jdv.17301","article-title":"Pityriasis rosea, COVID-19 and vaccination: New keys to understand an old acquaintance","volume":"35","author":"Busto-Leis","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R21-20240829","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1080\/21645515.2021.1963173","article-title":"Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine","volume":"17","author":"Cohen","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"R22-20240829","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1111\/jdv.17678","article-title":"Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford-AstraZeneca COVID-19 vaccine: Report of three cases from India","volume":"36","author":"Mehta","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R23-20240829","doi-asserted-by":"crossref","first-page":"e546","DOI":"10.1111\/jdv.17342","article-title":"Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine","volume":"35","author":"Cyrenne","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R24-20240829","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/ijd.15700","article-title":"Pityriasis rosea after mRNA COVID-19 vaccination","volume":"60","author":"Abdullah","year":"2021","journal-title":"Int J Dermatol"},{"key":"R25-20240829","first-page":"e721","article-title":"Pityriasis rosea developing after COVID-19 vaccination","volume":"35","author":"Marcantonio-Santa","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R26-20240829","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4103\/idoj.IDOJ_12_18","article-title":"Pityriasis Rosea: Clinical profile from central India","volume":"9","author":"Chhabra","year":"2018","journal-title":"Indian Dermatol Online J"},{"key":"R27-20240829","first-page":"50","article-title":"Pityriasis rosea. A statistical, clinical and laboratory investigation of 826 patients and matched healthy controls","volume":"42","author":"Bjornberg","year":"1962","journal-title":"Acta Derm Venereol"},{"key":"R28-20240829","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/njbcs.njbcs_10_16","article-title":"One-year review of pityriasis rosea among outpatients in Kano, Northwestern Nigeria","volume":"15","author":"Yusuf","year":"2018","journal-title":"Niger J Basic Clin Sci"},{"key":"R29-20240829","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1468-3083.2004.01105.x","article-title":"Atypical presentations of pityriasis rosea: case presentations","volume":"19","author":"Chuch","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R30-20240829","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1525-1470.2011.01549.x","article-title":"Coexistence of two atypical variants of pityriasis rosea: A case report and review of literature","volume":"29","author":"Sinha","year":"2012","journal-title":"Pediatr Dermatol"},{"key":"R31-20240829","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4103\/0019-5154.110855","article-title":"Pityriasis rosea with erythema multiforme\u2013Like lesions: An observational analysis","volume":"58","author":"Relhan","year":"2013","journal-title":"Indian J Dermatol"},{"key":"R32-20240829","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4103\/0378-6323.45113","article-title":"Clinicoepidemiological study of pityriasis rosea","volume":"74","author":"Sharma","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R33-20240829","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archpedi.161.5.503","article-title":"The natural history of pityriasis rosea in black American children: How correct is the \u201cclassic\u201d description?","volume":"161","author":"Amer","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R34-20240829","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/2229-5178.73253","article-title":"Acral pityriasis rosea in an infant with palmoplantar lesions: A novel manifestation","volume":"1","author":"Zawar","year":"2010","journal-title":"Indian Dermatol Online J"},{"key":"R35-20240829","first-page":"244","article-title":"Pityriasis rosea: A histopathologic study","volume":"66","author":"Prasad","year":"2000","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R36-20240829","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4103\/ijd.ijd_893_21","article-title":"Spectrum of Mucocutaneous Reactions to COVID-19 Vaccination: A Report from a Web-Based Study from India","volume":"67","author":"Sil","year":"2022","journal-title":"Indian J Dermatol"},{"key":"R37-20240829","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/pde.14564","article-title":"Symmetric blaschkoid pityriasis rosea in a child","volume":"38","author":"Bhanja","year":"2021","journal-title":"Pediatr Dermatol"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_1071_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:34:40Z","timestamp":1787769280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_1071_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_1071_23","relation":{},"ISSN":["0019-5154","1998-3611"],"issn-type":[{"value":"0019-5154","type":"print"},{"value":"1998-3611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"2023-11-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}